🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bio-Rad Laboratories, Inc.

BIO Healthcare
$369.23 $-1.25 (-0.34%)
Market Cap: $9.93 B
Gurus Holding
9
Popularity Rank
#648
% of Shares Held
15.04%
Net Activity (Q2 2026)
+$514,569.17

Guru Ownership Trend

Guru Analysis for Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories, Inc. (BIO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.49 B.

Top institutional holders include First Eagle Investment and John Rogers.

Institutional sentiment is currently Bullish. This is evidenced by a $514,569.17 net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 384.4%. Conversely, First Pacific Advisors reduced exposure by 33.0%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$48.5 M
Total Buy Value
New Buys 0
Additions 5
-$47.99 M
Total Sell Value
Reductions 2
Sold Out 2

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
4
Net Buyers
5

FAQs for Bio-Rad Laboratories, Inc. (BIO)

Major holders include First Eagle Investment ($927.5 M), John Rogers ($298.14 M), First Pacific Advisors ($101.63 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 4.04 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $514,569.17, with 5 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited BIO. The total reported sell value was $47.99 M.

Yes, 0 managers opened new positions in BIO, and 5 increased their existing holdings. The total reported buy value was $48.5 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.46% Reduce -5.8% 2,455,580 $927.5 M Q3 2026
3.10% Reduce -3.4% 789,341 $298.14 M Q3 2026
1.21% Reduce -33.0% 269,082 $101.63 M Q3 2026
0.02% Add 103.8% 192,711 $56.05 M Q2 2026
0.11% Add 9.1% 166,262 $48.82 M Q2 2026
0.01% Reduce -1.9% 114,719 $43.33 M Q3 2026
0.10% 26,750 $10.1 M Q3 2026
0.01% Add 384.4% 25,000 $7.34 M Q2 2026
0.01% New Buy 4,605 $1.74 M Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form